Advances in the diagnosis and treatment of human papillomavirus infections

Clinical Obstetrics and Gynecology

Volumn 42, Issue 2, 1999, Pages 206-220

  Sedlacek, Thomas V ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; FLUOROURACIL; IMIQUIMOD; PODOPHYLLIN; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID;

ARTICLE; CARBON DIOXIDE LASER; CONDYLOMA ACUMINATUM; EXCISION; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MALIGNANT TRANSFORMATION; PAPANICOLAOU TEST; PERSISTENT VIRUS INFECTION; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CARCINOMA IN SITU; VIRUS EXPRESSION; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; INCIDENCE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033401482     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199906000-00006     Document Type: Article

References (20)

1. Sedlacek TV, Cunnane MF. Condylomata acuminata: Diagnosis and management. Postgrad Obstet Gynecol. 1987;7:1-7.
2. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. 1997; 102:3-8.
3. Schneider A, Kirchoff T, Meinhardt G, Gissman L. Repeated evaluation of human papillornavirus 1b status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstet Gynecol. 1992;79:683-688.
4. Mosicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132:277-284.
5. Meisels A. Cytologic diagnosis of human papillomavirus: Influence of age and pregnancy stage. Acta Cytol. 1992;36:480-482.
6. Kataja V, Syrjanen M, Yliskoski M, et al. Risk factors associated with cervical human papillomavirus infections: A case control study. Am J Epidemiol. 1993;138:735-745.
7. Hildesheim A, Gravitt P, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-income women in Washington DC. Sex Trans Dis. 1993;20: 279-285.
8. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Trans Dis. 1996;23:333-341.
9. Svare EI, Kjaer SK, Worm AM, et al. Risk factors for HPV infection in women from sexually transmitted disease clinics: Comparison between two areas with different cervical cancer incidence. Int J Cancer. 1998:75:1-81.
10. Winkelstein W. Smoking and cervical cancer - Current Status: A Review. Am J Epidemiol. 1990;131:945-957.
11. Alani RM, Munger K. Human papillomaviruses and associated malignancies. J Clin Oncol. 1998;16:330-337.
12. Bosch FX, Manos M, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst. 1995;87:796-802.
13. Yamada T, Manos M, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol. 1997;71:2463-2472.
14. Conrad-Stoppler M, Ching K, Stoppler H, Clancy K, Schlegel R, Icenogle J. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J Virol. 1996;70:6987-6993.
15. Wheeler CE, Yamada T, Hildesheim A, Jenison SA. Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol. 1997;35:11-19.
16. Arany I, Tyring SK. Status of local cellular immunity in interferon-responsive and non-responsive human Papillomavirus associated lesions. Sex Trans Dis. 1996;23:475-480.
17. Apple RJ, Erlich HA, Klitz W, Manos M, Becker TM, Wheeler CM. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994;6;157-162.
18. Hines JF, Ghim S, Jenson B. Prospects for human papillomavirus vaccine development: Emerging HPV vaccines. Curr Opin Obstet Gynecol. 1996;10:15-19.
19. DeGruul TD, Bontkes HJ, Walboomers JMM, et al. Analysis of IgG reactivity against human papillomavirus type 16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: Results of a prospective study. Int J Cancer. 1996;68:731-738.
20. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol. 1995;141:680-689.